I-Terlippressin ye-terlipprete yenaliti

I-1mg / amandla e-vial

Isalathiso: Ukunyanga ukuphathwa kwe-eSophageal Ukopha.

Isicelo sekliniki: Inaliti ye-intravenous.

I-Terlipress kwi-acetate i-pharma 0.2 MG / ML yenaliti iqulethe i-terlippress esebenzayo ye-inatiment, eyi-Pouritity ye-Pouritat ePhatshini (le hormone ihlala iveliswa yi-pituitary gland efumaneka kwingqondo).

Iya kunikwa wena ngokuthi inaliti kwithambo.

I-Terlipress kwi-acetate i-pharma 0.2 MG / ML yesisombululo senaliti isetyenziselwa ukuphathwa:

Ukuphuma kwe-dilated (ukwandiswa) kwimibhobho yokutya okukhokelela kwisisu sakho (esibizwa ngokuba zii-Oeophagegeal vices).

• Unyango olungxamisekileyo lohlobo lwe-hiprome (i-hepatorenment syndrome (isilele ngokukhawuleza) kwizigulana ezinesifo se-Silrhois (isibindi se-Silver) kunye ne-ascites ropsy (isisu).

Eli chiza liya kuhlala linikwe ngugqirha kwithambo lakho. Ugqirha uya kuthatha isigqibo sedosi efanelekileyo yenu kwaye nentliziyo yakho kunye nokujikeleza kwegazi kuya kubekwa esweni rhoqo ngexesha lenaliti. Nceda ubuze ugqirha wakho ngolwazi oluthe kratya malunga nokusetyenziswa kwalo.

Sebenzisa kubantu abadala

1. Ulawulo lwexesha elifutshane lokwahluka kwe-Oesophagegeal

Ekuqaleni i-1-2 mg terlipress kwi-acetate (5-10 ml ye-terlipress kwi-acetate i-pharma 0.2 mg / mg / mg / ml isisombululo senaliti) sinikwa inaliti kwithambo lakho. Idosi yakho iya kuxhomekeka kubunzima bomzimba wakho.

Emva kwenaliti yokuqala, idosi yakho inokuncitshiswa ibe yi-1 Mg Terlipress kwi-acetate (5 ml) qho kwiiyure ezingama-4 ukuya kwezi-6.

2. Chwetheza i-1 Sypatorenal Syprome

Idosi eqhelekileyo yi-1 mg terlipress kwi-acetate qho kwiiyure ezi-6 ubuncinci iintsuku ezi-3. Ukuba ukuncitshiswa kwe-Serum kungaphantsi kwe-30% emva kweentsuku ezi-3 zonyango ugqirha wakho kufuneka athathele uphindandezele idosi ukuba ibe yi-2 MG qho kwiiyure ezi-2.

Ukuba akukho mpendulo kwi-terlippress kwi-acetate ye-pharma 0.2 mg / ml isisombululo senaliti okanye kwizigulana ezinempendulo epheleleyo, unyango nge-terlippress kwi-termetate i-pharma 0.2 mg / ML yenaliti kufuneka iphazamiseke.

Xa ukuncitshiswa kwe-serum kubonwa, unyango nge-terlippress kwi-acetate ye-pharma 0.2 MG / MG / ML yesisombululo kufuneka igcinwe ukuya kuthi ga kwiintsuku ezili-14 ubuninzi beentsuku ezili-14.

Sebenzisa abantu abadala

Ukuba ungaphezulu kweminyaka engama-70 ubudala uthetha nogqirha wakho ngaphambi kokuba ufumane i-terlippress kwi-acetate ye-pharma 0.2 mg / ml isisombululo senaliti.

Sebenzisa kwizigulana ezinengxaki zezintso

I-Terlipress kwi-acetate i-pharma 0.2 MG / ML yesisombululo senaliti kufuneka isetyenziswe ngononophelo kwizigulana ezinengxaki yokungaphumeleli kwizintso.

Sebenzisa kwizigulana ngeengxaki zesibindi

Akukho luhlengahlengiso lwe-Dose luyafuneka kwizigulana ezinesibindi sokusilela.

Sebenzisa abantwana kunye nolutsha

I-Terlipress kwi-acetate i-pharma 0.2 MG / ML yenaliti ayicetyiswa ukuba isetyenziswe ebantwaneni nakulutsha olungeyongo.

Ixesha lonyango

Ukusetyenziswa kweli chiza kunqunyelwe kwiintsuku ezi-2 ukuya kwezi-3 kulawulo lwexesha elifutshane lokwahlukahluka kwe-oesophagegeal the ntlobo yeentsuku ezili-14 zonyango lwe-hepatoreal, kuxhomekeke kwimeko yemeko yakho.